Intracerebral Hemorrhage Clinical Trials in New York, New York

5 studies are recruiting for intracerebral hemorrhage in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

   The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Locations

   31 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT04916210 on ClinicalTrials.gov

2. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

   The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is tha…

   Stage

   Phase 3

   Ages

   18 to 80

   Site

   Mount Sinai West, New York, New York

   Locations

   89 in total

   Run by

   Joseph Broderick, MD

   See if you can join NCT07227246 on ClinicalTrials.gov

3. Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

   The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.

   Stage

   Not phased

   Ages

   18 to 100

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Locations

   20 in total

   Run by

   Zeenat Qureshi Stroke Institute

   See if you can join NCT06402968 on ClinicalTrials.gov

4. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

   Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Mount Sinai West, New York, New York

   Locations

   187 in total

   Run by

   Yale University

   See if you can join NCT03907046 on ClinicalTrials.gov

5. Evaluating a Prototype CT Scan for ICH Evacuation

   The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of th…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mount Sinai West, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT07455201 on ClinicalTrials.gov